Reply: Managing Atypical Fungal Endocarditis: Better Be Prepared Than Improvize?
Genichiro Fujioka, Jacob A. Powell, Michael Tang

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Thank you Drs Khlidj and Ahmed for your interest and bringing up important points to discuss about our paper.1
Drs Khlidj and Ahmed propose that transthoracic echocardiography (TTE) should be used in all patients with fungemia to rule out vegetation like in our patient without common risk factors. While European guidelines recommend a screening TTE in patients with candidemia, the more recent Infectious Disease Society of America guidelines do not recommend this practice as the prevalence of candida endocarditis in patients with candidemia is as low as 1.9%.2 However, these same guidelines suggest a TTE is warranted when blood cultures are persistently positive, patients have fever despite treatment, and there are new heart failure symptoms, embolism, or a new murmur. A TTE should also be done in higher-risk individuals with risk factors for candida endocarditis.
The letter also suggests that the initial antifungal therapy failure was a result of multidrug resistance. Although we do not have sensitivities for the Candida parapsilosis found in our patient, it was unlikely that drug resistance played a significant role in treatment resistance. Treating C. parapsilosis with echinocandins typically requires a higher minimal inhibitory concentration than that for other Candida species, but resistance to polyenes is rare.3 It is possible that the C. parapsilosis found in our patient was resistant to micafungin and/or liposomal amphotericin B, but it would be exceedingly rare and would not explain the effectiveness of combined therapy. Rather, it is more likely that combination therapy was more effective at treating resistance due to biofilm production.4
Due to the large size of vegetation and the persistent fungemia, early surgical intervention would have been preferred over antifungal therapy alone.5 However, perioperative optimization of the patient is still critical in decreasing morbidity and mortality from cardiac surgery.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Fujioka G.Powell J.A.Candida parapsilosis endocarditis of the native tricuspid valve in a patient without common risk factors JACC Case Rep 202510507910.1016/j.jaccas.2025.105079 PMC 1278976340815246 · doi ↗ · pubmed ↗
- 2Thompson G.R.III Jenks J.D.Baddley J.W.Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management Clin Microbiol Rev 3632023 e 000192310.1128/cmr.00019-23PMC 1051279337439685 · doi ↗ · pubmed ↗
- 3Gabaldón T.Threats from the Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens Microbiol Mol Biol Rev 8842024 e 000292310.1128/mmbr.00029-23PMC 1165372639508581 · doi ↗ · pubmed ↗
- 4Tits J.Cammue B.P.A.Thevissen K.Combination therapy to treat fungal biofilm-based infections Int J Mol Sci 21222020887310.3390/ijms 2122887333238622 PMC 7700406 · doi ↗ · pubmed ↗
- 5Baddour L.M.Wilson W.R.Bayer A.S.Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association Circulation 1321520151435148610.1161/CIR.000000000000029626373316 · doi ↗ · pubmed ↗
